Transcatheter Edge-to-Edge Mitral Valve Repair (TEER)

TEER is a new, innovative technique that treats mitral heart disease in dogs. If left untreated, it can lead to Congestive Heart Failure (CHF).

It involves the use of an implant (V-Clamp) through a catheter into the beating heart without any cardiopulmonary bypass. Overall, this reduces blood backflow and helps the heart pump more efficiently.

• Much lower risks
• Lesser post-op medications
• Faster surgery recovery & discharge of 2-3 days

What is Myxomatous Mitral Valve Disease (MMVD)?

MMVD is the most common heart disease in dogs, particularly affecting older, small breeds.  A dog’s lifespan and quality of life can be greatly reduced as such.

It is caused by the weakening of the mitral valve, leading to a backflow of blood from the heart into the lungs. This backflow forces the heart to work harder to circulate oxygenated blood, gradually enlarging the heart and straining its capacity.

While there is no cure for MMVD, early intervention and appropriate treatment can slow the disease’s progression and improve the affected dog’s well-being.

• Heart murmurs
• Fatigue or fainting during activities
• Decreased appetite & weight loss

Contact us to schedule a consultation and discuss how we can help your beloved companion enjoy a healthier, more active life.

Is this procedure suitable for my dog? 

The procedure is suitable for dogs with Mitral Valve Disease Stage B2, C and D. There is no age limit. All potential candidates will need to be fully assessed and screened for suitability.

How does TEER’s V-Clamp work? 

The V-Clamp is the veterinary counterpart to the human MitraClip. 

It is approximately 8 mm in length, and implanted to clamp together the two mitral valve leaflets in patients, reducing backflow of blood through the valve.

The veterinary V-Clamp has been available for the last 3 years, while the human MitraClip has been successfully implanted in over 150,000 humans worldwide and demonstrated superior results over medical treatment.

Are there any significant risks for TEER procedure?

All forms of surgeries, including cardiac, may have complications. Clinical evaluations of TEER over the past years show low procedural risk and significant reductions in mitral disease severity. 

MinimallyInvasive

ImprovedQuality of Life

ProactiveCare